EX-10.22 8 d503089dex1022.htm EX-10.22 API DEVELOPMENT AGREEMENTApi Development Agreement • May 5th, 2020 • New York
This API DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of July 12, 2012 (the “Effective Date”) by and between Aratana Therapeutics Inc., a Delaware corporation (“Aratana”) and RaQualia Pharma Inc., a Japanese corporation (“RaQualia”). Aratana and RaQualia are referred to herein individually as a “Party” and collectively as the “Parties”.
… Cannabidiol (CBD) Active Pharmaceutical Ingredient Development Agreement with The State Government of Victoria set to conclude in early 2020Api Development Agreement • October 14th, 2019
